Related Experiment Video
Updated: Jun 27, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
Age-related macular degeneration
Hanna R Coleman1, Chi-Chao Chan, Frederick L Ferris
1Division of Epidemiology and Clinical Research, National Eye Institute, National Institutes of Health, Bethesda, MD, USA.
Age-related macular degeneration (AMD) is a leading cause of vision loss. Treatments like antioxidant vitamins, zinc, and ranibizumab injections show promise in managing AMD progression and vision.
Area of Science:
- Ophthalmology
- Genetics
- Molecular Biology
Background:
- Age-related macular degeneration (AMD) is a primary cause of vision impairment in older adults, particularly those of European descent.
- Key risk factors include advanced age, cigarette smoking, and specific genetic markers like complement factor H and LOC387715/HtrA1.
- The exact pathogenesis of AMD remains unclear, but oxidative stress and inflammation are suspected contributors.
Purpose of the Study:
- To review current understanding of age-related macular degeneration (AMD) risk factors, pathogenesis, and treatment options.
- To highlight the role of genetic and environmental factors in AMD development.
- To discuss emerging therapeutic strategies for AMD.
Main Methods:
- Review of epidemiological data and genetic association studies for AMD risk factors.
- Analysis of the role of oxidative stress and inflammation in AMD pathogenesis.
- Evaluation of clinical trial outcomes for antioxidant/zinc supplementation and ranibizumab therapy.
Main Results:
- Increasing age and smoking are significant risk factors for AMD.
- Complement factor H and LOC387715/HtrA1 are identified as key genetic risk factors.
- Antioxidant vitamins and zinc show a ~25% risk reduction for advanced AMD.
- Intravitreal ranibizumab stabilizes or improves vision in neovascular AMD.
Conclusions:
- AMD is influenced by age, smoking, and specific genetic predispositions.
- Oxidative stress and inflammation are implicated in AMD pathogenesis.
- Current treatments, including nutritional supplements and anti-VEGF therapy, offer therapeutic benefits for AMD management.
More Related Videos
Related Concept Videos
Diabetic Retinopathy
Photoreceptors and Visual Pathways
Alzheimer Disease l: Introduction
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
iPS Cell Differentiation

